BIOBio-Rad Laboratories, Inc.
307.49USD-2.06%Mkt Cap: 8.22B USDP/E: 51.21Last update: 2026-06-01

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates throug…

Indicators:|

Key Statistics

Company
Market Cap8.22B USD
Enterprise Value8.18B USD
Revenue (TTM)2.59B USD
Gross Profit1.34B USD
Net Income (TTM)759.90M USD
Revenue/Share95.80 USD
Last Price307.49 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7.5K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS0905722072
Valuation
P/E (Trailing)51.21
P/E (Forward)32.14
PEG4.01
EV/EBITDA18.38
EV/Revenue3.16
P/S3.23
P/B1.22
EPS (TTM)6.01
EPS (Forward)9.72
52W Range
211.4373% of range343.12
52W High343.12 USD
52W Low211.43 USD
Profitability
Gross Margin51.87%
Oper. Margin5.76%
EBITDA Margin17.17%
Profit Margin29.42%
ROE10.20%
ROA7.18%
Growth
Revenue Growth1.10%
Earnings Growth
Cash Flow & Leverage
Operating CF532.20M USD
CapEx (TTM)157.60M USD
FCF Margin8.87%
FCF Yield2.79%
Net Debt-186.50M USD
Net Debt/EBITDA-0.42
Balance Sheet
Debt/Equity0.19
Current Ratio3.21
Quick Ratio2.19
Book Value/Sh255.37 USD
Cash/Share58.47 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split2:1
Split DateMar 8, 2002
Analyst Consensus
Rating2.8 (Hold)
Target (Mean)297.00 USD
Target Range275.00 USD320.00 USD
# Analysts5
Ownership
Shares Out.21.70M
Float20.90M
Insiders16.38%
Institutions94.42%
Short Interest
Short Ratio0.0d
Short % Float0.00%
Short % Out.0.00%
Shares Short46
Short (prev mo.)29
Technical
SMA 50277.50 (+10.8%)
SMA 200293.50 (+4.8%)
Beta1.06
S&P 52W Chg27.70%
Avg Vol (30d)402.96K
Avg Vol (10d)557.46K
Technical Indicators
RSI (14)69.6
MACD9.0529
MACD Signal2.2749
MACD Hist.+6.7781
BB Upper320.11 USD
BB Middle271.01 USD
BB Lower221.91 USD
BB Width36.24%
ATR (14)11.15 USD
Vol Ratio (20d)0.54x